- Home
- LEGH vs BVS Comparison
LEGH vs BVS Comparison
Compare LEGH & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGH
- BVS
- Stock Information
- Founded
- LEGH 2005
- BVS 2011
- Country
- LEGH United States
- BVS United States
- Employees
- LEGH N/A
- BVS N/A
- Industry
- LEGH Homebuilding
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LEGH Consumer Discretionary
- BVS Health Care
- Exchange
- LEGH Nasdaq
- BVS Nasdaq
- Market Cap
- LEGH 608.5M
- BVS 656.9M
- IPO Year
- LEGH 2018
- BVS 2021
- Fundamental
- Price
- LEGH $24.21
- BVS $7.82
- Analyst Decision
- LEGH Buy
- BVS Strong Buy
- Analyst Count
- LEGH 2
- BVS 4
- Target Price
- LEGH $29.00
- BVS $15.00
- AVG Volume (30 Days)
- LEGH 84.3K
- BVS 339.2K
- Earning Date
- LEGH 05-08-2025
- BVS 05-06-2025
- Dividend Yield
- LEGH N/A
- BVS N/A
- EPS Growth
- LEGH 14.29
- BVS N/A
- EPS
- LEGH 2.48
- BVS N/A
- Revenue
- LEGH $184,191,000.00
- BVS $573,280,000.00
- Revenue This Year
- LEGH $3.55
- BVS N/A
- Revenue Next Year
- LEGH $8.46
- BVS $6.09
- P/E Ratio
- LEGH $9.76
- BVS N/A
- Revenue Growth
- LEGH N/A
- BVS 11.89
- 52 Week Low
- LEGH $19.42
- BVS $3.90
- 52 Week High
- LEGH $29.31
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- LEGH 45.98
- BVS 37.22
- Support Level
- LEGH $23.37
- BVS $7.56
- Resistance Level
- LEGH $25.35
- BVS $8.66
- Average True Range (ATR)
- LEGH 1.26
- BVS 0.61
- MACD
- LEGH 0.01
- BVS -0.05
- Stochastic Oscillator
- LEGH 58.29
- BVS 28.40
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.